Autopsy report · NCT01726322

Ovarian Reserve in Premenopausal Breast Cancer

“As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 7 years 10 months before it stopped.
• 216 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Cancer Trials Ireland

Sponsor type

University, hospital or other

Conditions

Premenopausal Breast Cancer; Breast Cancer

Participants

216

Sites

10

Countries

Ireland

Trials that died the same way

• Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
  “The study team decided to not move forward with enrolling patients because funding was not identified to support the project.” (63% match in meaning)
• Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
  “The sponsor decided to terminate the study due to financial issues following an FDA request for a partial clinical hold.” (62% match in meaning)
• Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
  “Study closed due to funding, 0 patient accrual.” (62% match in meaning)
• Consolidation Therapy in Patients With Metastatic Solid Malignancies
  “Sponsor decision to discontinue study.” (62% match in meaning)
• Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers
  “Sponsor decision to terminate the study” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.